Bio Protocol, one of the leading DeSci platforms, has officially gone multichain, expanding to Solana to supercharge speed.
Author: Sahil Thakur
Bio Protocol, one of the leading DeSci platforms, has officially gone multichain, expanding to Solana to supercharge speed, accessibility, and real-world experimentation. While Ethereum remains the home base, Solana’s lower fees and higher throughput now power a growing chunk of Bio’s ecosystem.
And that includes funding biotech breakthroughs, powering community-led BioDAOs, and rewarding contributors – all without sacrificing decentralization.
At its core, Bio Protocol is a liquidity layer and launchpad for biotech and scientific IP. Through BioDAOs, researchers, patients, and investors come together to fund and govern high-impact science, from longevity to rare diseases.
Its native token, $BIO, is used for governance, staking, auctions, and curation. Token holders back research through staking, while “IP-NFTs” represent research rights like patents or clinical data.
Over $70 million has already been raised through the Bio ecosystem. Key players like Binance Labs, VitaDAO, Molecule, and even top academic institutions are on board. And now, Solana joins that list.
Ethereum gave Bio the foundation it needed – strong tooling, security, and DeFi integrations. But to scale, it needed more:
Rather than migrate, Bio went multichain. It launched on Solana using Wormhole’s Native Token Transfers (NTT) framework. This keeps the token supply locked on Ethereum while enabling Solana-native transfers.
Users can now move $BIO between chains using bridge.bio.xyz, and Solana wallets like Phantom are fully supported.
As of September 2025, Solana supports the full $BIO experience:
Over 125M $BIO is staked, and 13+ BioDAOs are queued to launch. A 3M $BIO airdrop was also distributed to early contributors after the Solana milestone.
Curetopia ($CURES) became the first BioDAO to launch on Solana. It focuses on rare diseases and used Solana’s low-cost design to run accessible token sales and rewards.
Other projects are also adapting – Molecule, VitaDAO, and even Solana-native DeSci apps like pump.science have partnered for integrations.
Moving to Solana allows Bio Protocol to offer:
The shift also brings new use cases — like applying Bio to quantum biology, women’s health, and even microbiome research.
While Solana is live, Base (Coinbase L2) is next. The proposal is in governance and could unlock a strong DeFi layer for Bio Protocol, particularly for collateral-backed lending and dApp access.
Integrations with oracle provider Redstone, L2 DeFi tools, and new DAO tools are on the roadmap.
Our Crypto Talk is committed to unbiased, transparent, and true reporting to the best of our knowledge. This news article aims to provide accurate information in a timely manner. However, we advise the readers to verify facts independently and consult a professional before making any decisions based on the content since our sources could be wrong too. Check our Terms and conditions for more info.
Bitmine Purchase $236M in ETH as Lee Calls It Wartime Asset
Welf Finance Launches Regulated Wealth Platform in DIFC
AAVE Token Goes Live Natively on Solana via Sunrise DeFi
Ethereum Foundation Unstaking ETH Sparks Sell-Off Speculation
Bitmine Purchase $236M in ETH as Lee Calls It Wartime Asset
Welf Finance Launches Regulated Wealth Platform in DIFC
AAVE Token Goes Live Natively on Solana via Sunrise DeFi
Ethereum Foundation Unstaking ETH Sparks Sell-Off Speculation
